Cytokine-based Immunointervention in the Treatment of Autoimmune Diseases

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 2003 Apr 18

PMID 12699404

Citations 13

Authors

L Adorini

Affiliations

Soon will be listed here.

Citing Articles

Immunomodulatory Effect of Vitamin C on Proinflammatory Cytokines Production in Ossimi Lambs () with Pneumonic Pasteurellosis.

Rizk M, El-Sayed S, Salman D, Marghani B, Gadalla H, Sayed-Ahmed M Animals (Basel). 2021; 11(12).

PMID: 34944151 PMC: 8697947. DOI: 10.3390/ani11123374.

Relationships between Cytokine Levels and Disease Parameters during the Development of a Collagen-induced Arthritis Model in Cynomolgus Macaques ().

Choi E, Kim S Comp Med. 2019; 69(3):228-239.

PMID: 31068244 PMC: 6591675. DOI: 10.30802/AALAS-CM-18-000058.

The Potential of Frog Skin-Derived Peptides for Development into Therapeutically-Valuable Immunomodulatory Agents.

Pantic J, Jovanovic I, Radosavljevic G, Arsenijevic N, Conlon J, Lukic M Molecules. 2017; 22(12).

PMID: 29236056 PMC: 6150033. DOI: 10.3390/molecules22122071.

Bolstering Immunity through Pattern Recognition Receptors: A Unique Approach to Control Tuberculosis.

Pahari S, Kaur G, Aqdas M, Negi S, Chatterjee D, Bashir H Front Immunol. 2017; 8:906.

PMID: 28824632 PMC: 5539433. DOI: 10.3389/fimmu.2017.00906.

Current prospects of type II interferon γ signaling and autoimmunity.

Green D, Young H, Valencia J J Biol Chem. 2017; 292(34):13925-13933.

PMID: 28652404 PMC: 5572907. DOI: 10.1074/jbc.R116.774745.

References

Ferrante P, Fusi M, Saresella M, Caputo D, Biasin M, Trabattoni D . Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis. J Immunol. 1998; 160(3):1514-21. View

DHaens G, van Deventer S, Van Hogezand R, Chalmers D, Kothe C, Baert F . Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial. Gastroenterology. 1999; 116(5):1029-34. DOI: 10.1016/s0016-5085(99)70005-3. View

Liu J, Marino M, Wong G, Grail D, Dunn A, Bettadapura J . TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med. 1998; 4(1):78-83. DOI: 10.1038/nm0198-078. View

LeMaistre C . DAB(389)IL-2 (denileukin diftitox, ONTAK): other potential applications. Clin Lymphoma. 2001; 1 Suppl 1:S37-40. View

Inaba K, Kitaura M, Kato T, Watanabe Y, KAWADE Y, Muramatsu S . Contrasting effect of alpha/beta- and gamma-interferons on expression of macrophage Ia antigens. J Exp Med. 1986; 163(4):1030-5. PMC: 2188081. DOI: 10.1084/jem.163.4.1030. View

Tak P, Hart B, Kraan M, Jonker M, Smeets T, Breedveld F . The effects of interferon beta treatment on arthritis. Rheumatology (Oxford). 1999; 38(4):362-9. DOI: 10.1093/rheumatology/38.4.362. View

Rapoport M, Jaramillo A, Zipris D, Lazarus A, Serreze D, Leiter E . Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med. 1993; 178(1):87-99. PMC: 2191073. DOI: 10.1084/jem.178.1.87. View

Comabella M, Balashov K, Issazadeh S, Smith D, Weiner H, Khoury S . Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy. J Clin Invest. 1998; 102(4):671-8. PMC: 508928. DOI: 10.1172/JCI3125. View

Mathisen P, Tuohy V . Gene therapy in the treatment of autoimmune disease. Immunol Today. 1998; 19(3):103-5. DOI: 10.1016/s0167-5699(97)01214-0. View

10.

Dalum I, Butler D, Jensen M, Hindersson P, Steinaa L, Waterston A . Therapeutic antibodies elicited by immunization against TNF-alpha. Nat Biotechnol. 1999; 17(7):666-9. DOI: 10.1038/10878. View

11.

Panitch H, Hirsch R, Haley A, Johnson K . Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet. 1987; 1(8538):893-5. DOI: 10.1016/s0140-6736(87)92863-7. View

12.

Baker D, Butler D, Scallon B, ONeill J, Turk J, Feldmann M . Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur J Immunol. 1994; 24(9):2040-8. DOI: 10.1002/eji.1830240916. View

13.

Adorini L . Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int Immunopharmacol. 2002; 2(7):1017-28. DOI: 10.1016/s1567-5769(02)00049-8. View

14.

Wahl S . TGF-beta: a balancing act. Int Rev Immunol. 1998; 16(5-6):553-80. DOI: 10.3109/08830189809043009. View

15.

Abramson S, Amin A . Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage. Rheumatology (Oxford). 2002; 41(9):972-80. DOI: 10.1093/rheumatology/41.9.972. View

16.

Kuroda Y, Shimamoto Y . Human tumor necrosis factor-alpha augments experimental allergic encephalomyelitis in rats. J Neuroimmunol. 1991; 34(2-3):159-64. DOI: 10.1016/0165-5728(91)90125-q. View

17.

Zaccone P, Hutchings P, Nicoletti F, Penna G, Adorini L, Cooke A . The involvement of IL-12 in murine experimentally induced autoimmune thyroid disease. Eur J Immunol. 1999; 29(6):1933-42. DOI: 10.1002/(SICI)1521-4141(199906)29:06<1933::AID-IMMU1933>3.0.CO;2-3. View

18.

Groux H, Bigler M, De Vries J, Roncarolo M . Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med. 1996; 184(1):19-29. PMC: 2192687. DOI: 10.1084/jem.184.1.19. View

19.

Furlan R, Brambilla E, Ruffini F, Poliani P, Bergami A, Marconi P . Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes. J Immunol. 2001; 167(3):1821-9. DOI: 10.4049/jimmunol.167.3.1821. View

20.

. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Neurology. 1999; 53(3):457-65. View